GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 Vaccine

Описание к видео GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 Vaccine

Investigative mRNA vaccine programs scale from target-centric research to progressing candidates through the drug development process, challenges arise when determining the optimal path forward.

Комментарии

Информация по комментариям в разработке